Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase 1/2 3 Phase 2/3 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Breast Neoplasms 22 Colorectal Neoplasms 14 Ovarian Neoplasms 12 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Neoplasms 8 Nasopharyngeal Carcinoma 8 Leukemia, Myeloid, Acute 7 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Fallopian Tube Neoplasms 6 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Esophageal Squamous Cell Carcinoma 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Large B-Cell, Diffuse 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Multiple Myeloma 2

Interventions

Doxorubicin 25 Ifosfamide 22 Radiotherapy 17 Etoposide 11 Vincristine 10 Cyclophosphamide 10 Filgrastim 8 Dactinomycin 8 Trabectedin 7 Chemotherapy, Adjuvant 5 pazopanib 4 Cisplatin 4 Topotecan 3 Radiation 3 Neoadjuvant Therapy 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Dacarbazine 3 sargramostim 2 etoposide phosphate 2 eribulin 2 Observation 2 Methotrexate 2 Mesna 2 Imatinib Mesylate 2 Gemcitabine 2 Epirubicin 2 Docetaxel 2 Dexrazoxane 2 Carboplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma × Drug Therapy × Clear all

NCT04307277 2026-04-14

CHIC-STS01

Institut Claudius Regaud

Phase 3 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡